Lab slip analysis is the internal review process carriers and BGAs use to confirm that requested laboratory testing on an applicant aligns with underwriting guidelines, age and amount charts, and case specifics before the exam is completed. It involves checking that the correct tests are ordered, that additional requirements such as EKGs or special panels are included when needed, and that unnecessary tests are avoided for cost and client experience reasons. Effective lab slip analysis reduces the risk of incomplete underwriting evidence, minimizes re draws, and helps control expenses. It also allows underwriters to tailor testing for impaired risk cases, foreign travel, heavy build, or other special circumstances.

In real world operations, lab slip analysis may occur automatically through vendor systems or manually by case managers and underwriters. For example, when a large indexed universal life policy is submitted on a 70 year old prospective insured, the system may automatically add expanded cardiac enzymes and an EKG to the lab slip based on age and amount rules. If the client has disclosed diabetes, underwriters might request additional A1C or microalbumin tests. BGAs sometimes review lab requisitions on complex cases to ensure that all carrier and reinsurance requirements will be satisfied in one visit. Advisors benefit when lab slip analysis is thorough because it reduces the need for second appointments, which can irritate clients and slow placement. By understanding that lab slip analysis is an important quality control step, producers can appreciate why some cases require more extensive testing and can better prepare clients for what to expect.